Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Beovu Risk of Retinal Vascular Occlusion May Be Greater Among Users With Certain Eye Problems: Report November 18, 2020 Irvin Jackson Add Your Comments According to a safety review conducted by Novartis, patients with prior eye inflammation problems may face a higher risk of experiencing severe and vision threatening side effects from Beovu, known as retinal vasculitis or retinal vascular occlusion. Beovu (brolucizumab) was just introduced by Novartis in October 2019, for the treatment of wet age-related macular degeneration. However, only a few months later it was linked to a risk of serious eye problems that may result in blurry or distorted vision, including blindness. Retinal vasculitis is a form of eye inflammation impacting branches of the retinal artery. A retinal vascular occlusion occurs when the vein becomes blocked, which may result in complete loss of vision and permanent blindness caused by damage to the retina. Learn More About Beovu Lawsuit Side effects of Beovu have been linked to reports of severe and permanent vision problems, known as retinal vasculitis. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Beovu Lawsuit Side effects of Beovu have been linked to reports of severe and permanent vision problems, known as retinal vasculitis. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The American Society of Retina Specialists (ASRS) first raised concerns about the problems with Beovu eye inflammation in February 2020, warning members of the group it was aware of at least 14 cases of retinal vasculitis, 11 of which reportedly involved an occlusion. In response to the Beovu risk, some eye doctors decided to stop carrying the AMD injection in their inventory, and Novartis indicated it would launch an internal review. On November 13, Novartis issued a press release outlining the initial findings on patient characteristics and the likelihood of developing vision problems while taking Beovu. The company’s researchers analyzed data from the IRIS Registry, which included data on 12,000 patients treated with Beovu. According to the findings, patients who appeared to have the highest risk of experiencing retinal vasculitis (RV) and/or retinal vascular occlusion (RO) within six months after starting Beovu treatment were those who had experienced intraocular inflammation or RO in the previous year. Novartis’ findings indicate there was nearly a 4% chance of this category of patient experiencing retinal problems on Beovu, compared to just a 0.46% chance among other users. “We are pleased to share these findings that underscore the importance of carefully examining a patient for active ocular inflammation before injecting Beovu and throughout the course of treatment,” Marcia Kayath, Global Head of Medical Affairs and Chief Medical Officer at Novartis Pharmaceuticals, said in the press release. “Even with the great advancements made in treating wet AMD, data shows 50% of patients have unresolved fluid and a third require monthly injections, highlighting the persistent unmet need that Beovu may help address.” The findings are being presented this week at the American Academy of Ophthalmology (AAO) 2020 Annual Meeting in Las Vegas, Nevada. While Novartis initially marketed and sold the drug for months without warnings about the Beovu retina problems, a warning update in June 2020 added new information to the drug label. The company is now urging patients to seek immediate care from an ophthalmologist if their eyes become red, sensitive to light, painful, or develop changes in vision. Wet age-related macular degeneration affects about 20 million people worldwide. It is a chronic eye disorder which can caused blurred vision or blind spots. It usually occurs when abnormal blood vessels leak into the macula. The degeneration can be stopped, and sometimes vision loss can be reversed, if treated early enough. A number of former users who experienced vision problems from Beovu are now reviewing potential product liability lawsuits against the manufacturer, alleging Novartis placed the desire for profits before consumer safety by filing to disclose the risk of retinal vascular occlusion when the drug was introduced. Tags: Beovu, Novartis, Vision Loss, Wet Macular Degeneration More Beovu Lawsuit Stories Syfovre Side Effects Linked to Eye Inflammation, Vision Loss Problems, Ophthalmologists Warn July 20, 2023 Beovu Injection Caused Retinal Vasculitis and Other Vision Side Effects, Lawsuit Alleges December 14, 2022 Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss September 30, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Syfovre Side Effects Linked to Eye Inflammation, Vision Loss Problems, Ophthalmologists Warn July 20, 2023
Beovu Injection Caused Retinal Vasculitis and Other Vision Side Effects, Lawsuit Alleges December 14, 2022
Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss September 30, 2022
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)